Lupus erythematosus tumidus: clinical perspectives

References

• Hoffmann E. Demonstrationen: lupus erythematodes tumidus. Derm Zeitschr. 1909;16:159–160.
   Google Scholar
• Gougerot H, Burnier R. Lupus érythémateux tumidus. Bull Soc Fr Dermatol Syphil. 1930;37:1219–1292.
   Google Scholar
• Rockl H. [Erythematodes tumidus; a case history with reference to the problem of erythematodic lymphocytoma.]. Hautarzt. 1954;5:422–423.13221143
   PubMedGoogle Scholar
• Kuhn A, Bein D, Bonsmann G. The 100th anniversary of lupus erythematosus tumidus. Autoimmun Rev. 2009;8(6):441–448. doi:10.1016/j.autrev.2008.12.01019162244
   PubMed Web of Science ®Google Scholar
• Lehmann P, Hölzle E, Kind P, Goerz G, Plewig G. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol. 1990;22(2):181–187.2179293
   PubMed Web of Science ®Google Scholar
• Kuhn A, Sonntag M, Richter-Hintz D, et al. Phototesting in lupus erythematosus tumidus—review of 60 patients. Photochem Photobiol. 2001;73(5):532. doi:10.1562/0031-8655(2001)073<0532:PILETR>2.0.CO;211367576
   PubMed Web of Science ®Google Scholar
• Kuhn A, Sonntag M, Richter-Hintz D, et al. Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol. 2001;45(1):86–95. doi:10.1067/mjd.2001.11458911423840
   PubMed Web of Science ®Google Scholar
• Kuhn A, Sonntag M, Ruzicka T, Lehmann P, Megahed M. Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J Am Acad Dermatol. 2003;48(6):901–908. doi:10.1067/mjd.2003.43512789183
   PubMed Web of Science ®Google Scholar
• Alexiades-Armenakas MR, Baldassano M, Bince B, et al. Tumid lupus erythematosus: criteria for classification with immunohistochemical analysis. Arthritis Rheum. 2003;49(4):494–500. doi:10.1002/art.1120612910555
   PubMed Web of Science ®Google Scholar
• Rodriguez-Caruncho C, Bielsa I, Fernández-Figueras MT, Roca J, Carrascosa JM, Ferrándiz C. Lupus erythematosus tumidus: a clinical and histological study of 25 cases. Lupus. 2015;24(7):751–755. doi:10.1177/096120331456020425413356
   PubMed Web of Science ®Google Scholar
• Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus. 2010;19(9):1050–1070. doi:10.1177/096120331037004820693199
   PubMed Web of Science ®Google Scholar
• Kuhn A, Ruzicka T. Classification of cutaneous lupus erythematosus In: Kuhn A, Lehmann P, Ruzicka T, editors. Cutaneous Lupus Erythematosus. New York: Springer; 2005:53–57.
   Google Scholar
• Callen JP. Clinically relevant information about cutaneous lupus erythematosus. Arch Dermatol. 2009;145(3):316–319. doi:10.1001/archdermatol.2008.58219289766
   PubMedGoogle Scholar
• Maize JCJ, Costner M. Tumid lupus erythematosus: a form of lupus erythematosus. Arch Dermatol. 2010;146(4):451 author reply 450-1. doi:10.1001/archdermatol.2010.15620404245
   PubMedGoogle Scholar
• Callen JP. Tumid lupus erythematosus: a form of lupus erythematosus - reply. Arch Dermatol. 2010;146(4):451–452. doi:10.1001/archdermatol.2010.5420404245
   PubMedGoogle Scholar
• Schmitt V, Meuth AM, Amler S, et al. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus. Br J Dermatol. 2010;162(1):64–73. doi:10.1111/j.1365-2133.2009.09401.x19712116
   PubMed Web of Science ®Google Scholar
• Mutasim D. Lupus erythematosus tumidus as a separate subtype of cutaneous lupus erythematosus. Br J Dermatol. 2010;163(1):230 author reply 231-2.20408831
   PubMed Web of Science ®Google Scholar
• Callen JP. Cutaneous lupus erythematosus: reflecting on practice-changing observations over the past 50 years. Clin Dermatol. 2018;36(4):442–449. doi:10.1016/j.clindermatol.2018.04.00230047428
   PubMed Web of Science ®Google Scholar
• Petri M, Orbai AM, Alarcõn GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–2686. doi:10.1002/art.3447322553077
   PubMed Web of Science ®Google Scholar
• Lipsker D, Mitschler A, Grosshans E, Cribier B. Could Jessner’s lymphocytic infiltrate of the skin be a dermal variant of lupus erythematosus? An analysis of 210 cases. Dermatology. 2006;213(1):15–22. doi:10.1159/00009283216778421
   PubMed Web of Science ®Google Scholar
• Weber F, Schmuth M, Fritsch P, Sepp N. Lymphocytic infiltration of the skin is a photosensitive variant of lupus erythematosus: evidence by phototesting. Br J Dermatol. 2001;144(2):292–296. doi:10.1046/j.1365-2133.2001.04017.x11251561
   PubMed Web of Science ®Google Scholar
• Rémy-Leroux V, Léonard F, Lambert D, et al. Comparison of histopathologic-clinical characteristics of Jessner’s lymphocytic infiltration of the skin and lupus erythematosus tumidus: multicenter study of 46 cases. J Am Acad Dermatol. 2008;58(2):217–223. doi:10.1016/j.jaad.2007.09.03918083273
   PubMed Web of Science ®Google Scholar
• Kim IS, Kim BR, Youn SW. Differentiation of Jessner’s lymphocytic infiltration of the skin from various chronic cutaneous lupus erythematosus subtypes by quantitative computer-aided image analysis. Dermatology. 2016;232(1):57–63. doi:10.1159/00044064826458204
   PubMed Web of Science ®Google Scholar
• Grönhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011;164(6):1335–1341. doi:10.1111/j.1365-2133.2011.10272.x21574972
   PubMed Web of Science ®Google Scholar
• Kuhn A, Sigges J, Biazar C, et al. Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database. Br J Dermatol. 2014;171(3):571–579. doi:10.1111/bjd.1300624673427
   PubMed Web of Science ®Google Scholar
• Sigges J, Biazar C, Landmann A, et al. Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) core set questionnaire in more than 1000 patients with cutaneous lupus erythematosus. Autoimmun Rev. 2013;12(7):694–702. doi:10.1016/j.autrev.2012.10.00523220353
   PubMed Web of Science ®Google Scholar
• Biazar C, Sigges J, Patsinakidis N, et al. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun Rev. 2013;12(3):444–454. doi:10.1016/j.autrev.2012.08.01923000206
   PubMed Web of Science ®Google Scholar
• Patsinakidis N, Gambichler T, Lahner N, Moellenhoff K, Kreuter A. Cutaneous characteristics and association with antinuclear antibodies in 402 patients with different subtypes of lupus erythematosus. J Eur Acad Dermatol Venereol. 2016;30(12):2097–2104. doi:10.1111/jdv.1376927431977
   PubMed Web of Science ®Google Scholar
• Verdelli A, Coi A, Marzano AV, et al. Autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol. 2019;33(4):742–752. doi:10.1111/jdv.15147.29924416
   PubMed Web of Science ®Google Scholar
• Stead J, Headley C, Ioffreda M, Kovarik C, Werth V. Coexistence of tumid lupus erythematosus with systemic lupus erythematosus and discoid lupus erythematosus: a report of two cases of tumid lupus. J Clin Rheumatol. 2008;14(6):338–341. doi:10.1097/RHU.0b013e31817d118318664992
   PubMed Web of Science ®Google Scholar
• Jolly M, Laumann AE, Shea CR, Utset TO. Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus. Lupus. 2004;13(1):64–69. doi:10.1191/0961203304lu473cr14870920
   PubMed Web of Science ®Google Scholar
• Rupec RA, Petropoulou T, Belohradsky BH, et al. Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease. Eur J Dermatol. 2000;10(3):184–189.10725815
   PubMed Web of Science ®Google Scholar
• Chen X, Wang S, Li L. A case report of lupus erythematosus tumidus converted from discoid lupus erythematosus. Medicine (Baltimore). 2018;97(16):e0375. doi:10.1097/MD.000000000001037529668590
   PubMed Web of Science ®Google Scholar
• Ruiz H, Sánchez JL. Tumid lupus erythematosus. Am J Dermatopathol. 1999;21(4):356–360.10446777
   PubMed Web of Science ®Google Scholar
• Lehrhoff S, Tzu J, Patel R, Sanchez M, Franks A. Lupus erythematosus tumidus with discoid lupus erythematosus-induced alopecia of the scalp. Dermatol Online J. 2011;17:10.
   Google Scholar
• Wozniacka A, Robak E, McCauliffe DP, Sysa-Jedrzejowska A. The evolution of multiple forms of cutaneous lupus erythematosus in the same patient over time. J Eur Acad Dermatol Venereol. 2008;22(10):1237–1239. doi:10.1111/j.1468-3083.2007.02594.x18826552
   PubMed Web of Science ®Google Scholar
• Choonhakarn C, Poonsriaram A, Chaivoramukul J. Lupus erythematosus tumidus. Int J Dermatol. 2004;43(11):815–818. doi:10.1111/j.1365-4632.2004.02073.x15533063
   PubMed Web of Science ®Google Scholar
• Reich A, Marcinow K, Bialynicki-Birula R. The lupus band test in systemic lupus erythematosus patients. Ther Clin Risk Manag. 2011;7(1):27–32. doi:10.2147/TCRM.S1014521339940
   PubMed Web of Science ®Google Scholar
• Cozzani E, Christana K, Rongioletti F, Rebora A, Parodi A. Lupus erythematosus tumidus: clinical, histopathological and serological aspects and therapy response of 21 patients. Eur J Dermatol. 2010;20(6):797–801.21030340
   PubMed Web of Science ®Google Scholar
• Vieira V, Del Pozo J, Yebra-Pimentel MT, Martínez W, Fonseca E. Lupus erythematosus tumidus: a series of 26 cases. Int J Dermatol. 2006;45(5):512–517. doi:10.1111/j.1365-4632.2004.02574.x16700782
   PubMed Web of Science ®Google Scholar
• Willemze R, Dijkstra A, Meijer CJLM. Lymphocytic infiltration of the skin (Jessner): a T‐cell lymphoproliferative disease. Br J Dermatol. 1984;110(5):523–529. doi:10.1111/j.1365-2133.1984.tb04674.x6372848
   PubMed Web of Science ®Google Scholar
• Cerroni L. Pseudolymphomas of the skin In: Cerroni L, editor. Skin Lymphoma. 4th ed. Oxford, UK: Wiley Blackwell; 2014:374–375.
   Google Scholar
• Pereira A, Ferrara G, Calamaro P, et al. The histopathological spectrum of pseudolymphomatous infiltrates in cutaneous lupus erythematosus. Am J Dermatopathol. 2018;40(4):247–253. doi:10.1097/DAD.000000000000094228654469
   PubMed Web of Science ®Google Scholar
• Privette ED, Werth VP. Update on pathogenesis and treatment of CLE. Curr Opin Rheumatol. 2013;25(5):584–590. doi:10.1097/BOR.0b013e32836437ba23872903
   PubMed Web of Science ®Google Scholar
• Patsinakidis N, Wenzel J, Landmann A, et al. Suppression of UV-induced damage by a liposomal sunscreen: a prospective, open-label study in patients with cutaneous lupus erythematosus and healthy controls. Exp Dermatol. 2012;21(12):958–961. doi:10.1111/exd.1203523171460
   PubMed Web of Science ®Google Scholar
• Kuhn A, Wozniacka A, Szepietowski JC, et al. Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol. J Invest Dermatol. 2011;131(8):1622–1630. doi:10.1038/jid.2011.10121593767
   PubMed Web of Science ®Google Scholar
• Ruland V, Haust M, Stilling RM, et al. Updated analysis of standardized photoprovocation in patients with cutaneous lupus erythematosus. Arthritis Care Res. 2013;65(5):767–776. doi:10.1002/acr.21867
   Web of Science ®Google Scholar
• Placzek M, Kerkmann U, Bell S, Koepke P, Przybilla B. Tobacco smoke is phototoxic. Br J Dermatol. 2004;150(5):991–993. doi:10.1111/j.1365-2133.2004.05818.x15149514
   PubMed Web of Science ®Google Scholar
• Mentens G, Lambert J, Nijsten T. Polymorphic light eruption may be associated with cigarette smoking and alcohol consumption. Photodermatol Photoimmunol Photomed. 2006;22(2):87–92. doi:10.1111/j.1600-0781.2006.00204.x16606413
   PubMed Web of Science ®Google Scholar
• Böckle BC, Sepp NT. Smoking is highly associated with discoid lupus erythematosus and lupus erythematosus tumidus: analysis of 405 patients. Lupus. 2015;24(7):669–674. doi:10.1177/096120331455963025411260
   PubMed Web of Science ®Google Scholar
• Chasset F, Bouaziz JD, Costedoat-Chalumeau N, Francès C, Arnaud L. Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis. Br J Dermatol. 2017;177(1):188–196. doi:10.1111/bjd.1531228112801
   PubMed Web of Science ®Google Scholar
• Chasset F, Francès C, Barete S, Amoura Z, Arnaud L. Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature. J Am Acad Dermatol. 2015;72(4):634–639. doi:10.1016/j.jaad.2014.12.02525648824
   PubMed Web of Science ®Google Scholar
• Kreuter A, Gaifullina R, Tigges C, Kirschke J, Altmeyer P, Gambichler T. Lupus erythematosus tumidus response to antimalarial treatment in 36 patients with emphasis on smoking. Arch Dermatol. 2009;145(3):244–248. doi:10.1001/archdermatol.2008.59219289751
   PubMedGoogle Scholar
• Shovman O, Tamar S, Amital H, Watad A, Shoenfeld Y. Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature. Clin Rheumatol. 2018;37(2):563–568. doi:10.1007/s10067-017-3884-229063464
   PubMed Web of Science ®Google Scholar
• Schneider SW, Staender S, Schlüter B, Luger TA, Bonsmann G. Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis. Arch Dermatol. 2006;142(1):115–116. doi:10.1001/archderm.142.1.11516415403
   PubMedGoogle Scholar
• Sohl S, Renner R, Winter U, et al. [Drug-induced lupus erythematosus tumidus during treatment with adalimumab]. Hautarzt. 2009;60(10):826–829. doi:10.1007/s00105-008-1699-419229504
   PubMed Web of Science ®Google Scholar
• Chogle AR, Shah CV, Murthy AK. Role of anti-tumor necrosis factor-α blockers in inducing lupus erythematosus tumidus in “rhupus syndrome.”. J Rheumatol. 2011;38(6):1218–1219. doi:10.3899/jrheum.10102021632691
   PubMed Web of Science ®Google Scholar
• Brown CW, Deng JS. Thiazide diuretics induce cutaneous lupus-like adverse reaction. Clin Toxicol. 1995;33(6):729–733.
   Web of Science ®Google Scholar
• Bockle BC, Baltaci M, Weyrer W, Sepp NT. Bortezomib-induced lupus erythematosus tumidus. Oncologist. 2009;14(6):637–639. doi:10.1634/theoncologist.2008-019719474161
   PubMed Web of Science ®Google Scholar
• Aguayo-Leiva I, Vano-Galvan S, Carrillo-Gijon R, Jaén-Olasolo P. Lupus tumidus induced by bortezomib not requiring discontinuation of the drug. J Eur Acad Dermatol Venereol. 2010;24(11):1363–1364. doi:10.1111/j.1468-3083.2010.03643.x20337821
   PubMed Web of Science ®Google Scholar
• Schepis C, Lentini M, Siragusa M, Batolo D. ACE-inhibitor-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and lupus erythematosus tumidus. Dermatology. 2004;208(4):354–355. doi:10.1159/00007784915178923
   PubMed Web of Science ®Google Scholar
• Chamberlain AJ, Hollowood K, Turner RJ, Byren I. Tumid lupus erythematosus occurring following highly active antiretroviral therapy for HIV infection: a manifestation of immune restoration. J Am Acad Dermatol. 2004;51(5SUPPL). doi:10.1016/j.jaad.2004.04.020
   Web of Science ®Google Scholar
• Guarneri C, Lentini M, Polimeni G, Giuffrida R, Cannavò SP. Ustekinumab-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and lupus erythematosus tumidus. Br J Clin Pharmacol. 2016;81(4):792–794. doi:10.1111/bcp.1283726616890
   PubMed Web of Science ®Google Scholar
• Prieto-Barrios M, Rodriguez-Peralto J, Vico-Alonso C, et al. Lupus-like injection-site reaction to ixekizumab: report of two cases. Indian J Dermatol Venereol Leprol. 2018;84(5):610–613. doi:10.4103/ijdvl.IJDVL_786_1730073991
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Solomon M, Barzilai A, Shoenfeld Y. Lupus erythematosus tumidus induced by sex reassignment surgery. J Rheumatol. 2007;34(9):1938–1940.17696264
   PubMed Web of Science ®Google Scholar
• Kunz M, Konig IR, Schillert A, et al. Genome-wide association study identifies new susceptibility loci for cutaneous lupus erythematosus. Exp Dermatol. 2015;24(7):510–515. doi:10.1111/exd.1270825827949
   PubMed Web of Science ®Google Scholar
• Wenzel J, Zahn S, Tüting T. Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets. Lupus. 2010;19(9):1020–1028. doi:10.1177/096120331037004620693195
   PubMed Web of Science ®Google Scholar
• Obermoser G, Schwingshackl P, Weber F, et al. Recruitment of plasmacytoid dendritic cells in ultraviolet irradiation-induced lupus erythematosus tumidus. Br J Dermatol. 2009;160(1):197–200. doi:10.1111/j.1365-2133.2008.08873.x
   Web of Science ®Google Scholar
• Zahn S, Graef M, Patsinakidis N, et al. Ultraviolet light protection by a sunscreen prevents interferon-driven skin inflammation in cutaneous lupus erythematosus. Exp Dermatol. 2014;23(7):516–518. doi:10.1111/exd.1242824758584
   PubMed Web of Science ®Google Scholar
• Gambichler T, Pätzholz J, Schmitz L, Lahner N, Kreuter A. FOXP3+ and CD39+ regulatory T cells in subtypes of cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol. 2015;29(10):1972–1977. doi:10.1111/jdv.1312325808110
   PubMed Web of Science ®Google Scholar
• Gambichler T, Genc Z, Skrygan M, et al. Cytokine and chemokine ligand expression in cutaneous lupus erythematosus. Eur J Dermatol. 2012;22(3):319–323.22562806
   PubMed Web of Science ®Google Scholar
• Lembo S, Raimondo A. Polymorphic light eruption: what’s new in pathogenesis and management. Front Med. 2018;5(5):252. doi:10.3389/fmed.2018.00252
   Web of Science ®Google Scholar
• Dawe RS. Polymorphic Light Eruption. In: Katsambas AD, Lotti TM, Dessinioti C, D’Erme AM, editors. European Handbook of Dermatological Treatments. Berlin, Heidelberg: Springer; 2015;757–761.
   Google Scholar
• Thareja S, Paghdal K, Lien MH, Fenske NA. Reticular erythematous mucinosis - a review. Int J Dermatol. 2012;51(8):903–909. doi:10.1111/j.1365-4632.2011.05292.x22788804
   PubMed Web of Science ®Google Scholar
• Cinotti E, Merlo V, Kempf W, et al. Reticular erythematous mucinosis: histopathological and immunohistochemical features of 25 patients compared with 25 cases of lupus erythematosus tumidus. J Eur Acad Dermatol Venereol. 2015;29(4):689–697. doi:10.1111/jdv.1265425087914
   PubMed Web of Science ®Google Scholar
• Rongioletti F, Merlo V, Riva S, et al. Reticular erythematous mucinosis: a review of patients’ characteristics, associated conditions, therapy and outcome in 25 cases. Br J Dermatol. 2013;169(6):1207–1211. doi:10.1111/bjd.1257723937648
   PubMed Web of Science ®Google Scholar
• Kaatz M, Zelger B, Norgauer J, Ziemer M. Lymphocytic infiltration (Jessner-Kanof): lupus erythematosus tumidus or a manifestation of borreliosis? [10]. Br J Dermatol. 2007;157(2):403–405. doi:10.1111/j.1365-2133.2007.07997.x17573889
   PubMed Web of Science ®Google Scholar
• Weyers W, Bonczkowitz M, Weyers I, Weyers W, Bonczkowitz M, Weyers I. LE or not LE-that is the question: an unsuccessful attempt to separate lymphocytic infiltration from the spectrum of discoid lupus erythematosus. Am J Dermatopathol. 1998;20(3):225–232.9650693
   PubMed Web of Science ®Google Scholar
• Sparsa L, Afif N, Goetz J, et al. Jessner-Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus? Rheumatol Int. 2011;31(2):255–258. doi:10.1007/s00296-009-1169-z19823837
   PubMed Web of Science ®Google Scholar
• Akasu R, Kahn HJ, From L. Lymphocyte markers on formalin‐fixed tissue in Jessner’s lymphocytic infiltrate and lupus erythematosus. J Cutan Pathol. 1992;19(1):59–65.1556268
   PubMed Web of Science ®Google Scholar
• Wuyts L, Dandelooy J, Siozopolou V, Lambert J, Aerts O. Mepacrine as successful monotherapy for refractory Jessner–kanof disease: still an important drug in the dermatologic armamentarium. J Dermatolog Treat. 2017;28(3):276–278. doi:10.1080/09546634.2016.121466827686749
   PubMed Web of Science ®Google Scholar
• Kuhn A, Aberer E, Bata-Csörgő Z, et al. S2k guideline for treatment of cutaneous lupus erythematosus – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2017;31(3):389–404. doi:10.1111/jdv.1405327859683
   PubMed Web of Science ®Google Scholar
• Kuhn A, Richter-Hintz D, Oslislo C, Ruzicka T, Megahed M, Lehmann P. Lupus erythematosus tumidus A neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol. 2000;136(8):1033–1041.10926740
   PubMedGoogle Scholar
• Kreuter A, Gambichler T, Breuckmann F, et al. Pimecrolimus 1% cream for cutaneous lupus erythematosus. J Am Acad Dermatol. 2004;51(3):407–410. doi:10.1016/j.jaad.2004.01.04415337984
   PubMed Web of Science ®Google Scholar
• Kuhn A, Gensch K, Haust M, et al. Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial. J Am Acad Dermatol. 2011;65(1):54–64. doi:10.1016/j.jaad.2010.03.03721501887
   PubMed Web of Science ®Google Scholar
• Ochsendorf F. Use of antimalarials in dermatology. J Der Dtsch Dermatologischen Gesellschaft. 2010;8:829–844.
   PubMed Web of Science ®Google Scholar
• Marmor MF, Kellner U, Lai TYY, Melles RB, Mieler WF, Lum F. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123(6):1386–1394. doi:10.1016/j.ophtha.2016.01.05826992838
   PubMed Web of Science ®Google Scholar
• Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132(12):1453–1460. doi:10.1001/jamaophthalmol.2014.345925275721
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010;69(1):20–28. doi:10.1136/ard.2008.10176619103632
   PubMed Web of Science ®Google Scholar
• Kreuter A, Tigges C, Hunzelmann N, Oellig F, Lehmann P, Hofmann SC. Rituximab in the treatment of recalcitrant generalized lupus erythematosus tumidus. JDDG - J Ger Soc Dermatol. 2017;15(7):729–731.
   Web of Science ®Google Scholar